We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-17.26%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.29B
AUM Growth
-$744M
Cap. Flow
+$126M
Cap. Flow %
3.81%
Top 10 Hldgs %
18.14%
Holding
1,378
New
105
Increased
487
Reduced
524
Closed
187

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$6.95M
2
NKE icon
Nike
NKE
+$5.91M
3
UNH icon
UnitedHealth
UNH
+$5.38M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$5.36M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.93M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Healthcare 13.38%
3 Financials 10.48%
4 Consumer Discretionary 8.32%
5 Communication Services 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOXX
1126
DELISTED
VOXX International Corporation Class A
VOXX
$86K ﹤0.01%
30,000
RLJ icon
1127
RLJ Lodging Trust
RLJ
$1.65B
$84K ﹤0.01%
10,860
LRFC
1128
DELISTED
Logan Ridge Finance Corp
LRFC
$83K ﹤0.01%
4,444
CPE
1129
DELISTED
Callon Petroleum Company
CPE
$81K ﹤0.01%
14,700
+7,810
+113% +$192K
JPS
1130
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$81K ﹤0.01%
11,107
+617
+6% +$5.71K
GEG icon
1131
Great Elm Group
GEG
$67.4M
$80K ﹤0.01%
42,865
BKT icon
1132
BlackRock Income Trust
BKT
$340M
$79K ﹤0.01%
4,610
-1,833
-28% -$33.1K
STAY
1133
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$79K ﹤0.01%
+10,763
New +$124K
JRS icon
1134
Nuveen Real Estate Income Fund
JRS
$241M
$78K ﹤0.01%
11,559
PSEC icon
1135
Prospect Capital
PSEC
$1.14B
$75K ﹤0.01%
17,690
-8,863
-33% -$52.3K
GRCE
1136
Grace Therapeutics
GRCE
$44.6M
$75K ﹤0.01%
4,133
+2,582
+166% +$91.4K
CLDT
1137
Chatham Lodging
CLDT
$580M
$72K ﹤0.01%
+12,066
New +$169K
AM icon
1138
Antero Midstream
AM
$10.5B
$71K ﹤0.01%
33,904
-7,550
-18% -$36K
TCRT icon
1139
Alaunos Therapeutics
TCRT
$4.81M
$71K ﹤0.01%
193
GARS
1140
DELISTED
Garrison Capital Inc.
GARS
$70K ﹤0.01%
40,909
-400
-1% -$2.05K
PAA icon
1141
Plains All American Pipeline
PAA
$16.3B
$68K ﹤0.01%
12,817
-4,118
-24% -$56.5K
CNR
1142
DELISTED
Cornerstone Building Brands, Inc.
CNR
$68K ﹤0.01%
15,000
+5,000
+50% +$37.2K
PVLA
1143
Palvella Therapeutics
PVLA
$2.22B
$67K ﹤0.01%
371
+62
+20% +$15.6K
RITM icon
1144
Rithm Capital
RITM
$5.72B
$66K ﹤0.01%
13,092
+1,886
+17% +$27.3K
CMCM
1145
Cheetah Mobile
CMCM
$98.1M
$65K ﹤0.01%
6,204
MDWD icon
1146
MediWound
MDWD
$179M
$65K ﹤0.01%
5,886
-428
-7% -$7.9K
JMM icon
1147
Nuveen Multi-Market Income Fund
JMM
$55.2M
$64K ﹤0.01%
10,500
ICMB icon
1148
Investcorp Credit Management BDC
ICMB
$12.5M
$63K ﹤0.01%
25,895
-9,264
-26% -$55.7K
WPRT
1149
Westport Fuel Systems
WPRT
$36.7M
$63K ﹤0.01%
6,810
+200
+3% +$4.12K
PTE
1150
DELISTED
PolarityTE, Inc. Common Stock
PTE
$62K ﹤0.01%
2,309
+247
+12% +$13.4K

Similar funds

Oppenheimer & Co's Q1 2020 Portfolio in Review

As of Q1 2020, Oppenheimer & Co held 1,378 positions worth $3.29B, down 18% from $4.04B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co deployed $126M of net new capital in Q1 2020, opening 105 new positions and adding to 487 existing holdings. Its largest new stake was Hasbro: 50,954 shares worth $3.65M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Target, an estimated $6.95M trimmed.

  • Oppenheimer & Co's largest Q1 2020 buy was Hasbro: 50,954 shares worth $3.65M.
  • Oppenheimer & Co added most to Invesco QQQ Trust in Q1 2020, an estimated $24.5M increase.
  • Oppenheimer & Co's biggest Q1 2020 reduction was Target, cutting an estimated $6.95M.
  • Oppenheimer & Co fully exited Campbell Soup in Q1 2020, selling an estimated $3.76M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $3.29B portfolio in Q1 2020.
  • Oppenheimer & Co opened 105 new positions and closed 187 in Q1 2020.
  • Oppenheimer & Co's portfolio value fell 18% quarter-over-quarter to $3.29B.

Based on Oppenheimer & Co's 13F filing for Q1 2020, filed 8 May 2020.